BlackLine, which provides automation software for accounting and finance, announced the launch of a comprehensive suite of AI capabilities called Verity.
Executives at Novartis have not been shy about a desire to buy more companies, with cardiovascular a big focus. In total, the Swiss pharma has put $17.23 billion on the line in M&A and licensing deals this year.
Novartis has been investing heavily in its cardiovascular pipeline this year, forging partnerships with Flagship startup ProFound Therapeutics and China’s Argo Biopharmaceutical, among others.
Ori Biotech’s CEO said the prioritization of review by FDA, coupled to the impact of the technology, could shave up to three years off development timelines.
The Internal Revenue Service plans to shut down nine in-person Taxpayer Assistance Centers in six states as part of the administration’s cost-cutting moves.